- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05319327
Targeting DNA-methylation Fingerprints Linked to Ultra-Processed Foods Consumption to Prevent Non-communicable Diseases: the METHYL-UP Study (METHYL-UP)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators propose a controlled, randomized, parallel groups intervention study based on nutritional counseling to reduce UPF consumption. Eligible participants are adults (18-50 years old), men and women, with overweight or obesity (BMI 25-40 Kg/m2) with a high basal consumption of UPF (>35% of total intake in g/day).
Recruited participants will be randomly allocated into a control group or an intervention group. Participants in the control group will be provided with nutritional guidelines to follow a healthy diet based on a Mediterranean diet. Participants in the intervention group will follow a nutritional intervention program aimed to reduce UPF consumption. Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention. Nutritional counseling will be based on nutritional educational material such as encourage and discourage food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods.
Total intervention will last 6 months for both groups. During the intervention phase, a monthly interview with nutritionist/dietitian is scheduled. Face-to-face interviews will be carried out in months 2 and 4. Phone interviews will be carried out in months 1, 3 and 5. In the baseline and final visits (months 0 and 6) a sample and data collection will be performed.
Data collected will include general socio-demographical data (age, sex, educational level, working status, civil status, rural/urban status), lifestyle data (smoking habits, dietary habits, physical activity, sleeping habits), anthropometric data (height, weight, waist circumference, body composition), and clinic-phenotypical parameters (blood pressure, medication, adverse effects, disease prevalence). Biological sample collection will include blood, urine, saliva and feces. Biochemical and blood cells parameters will be measured (blood cell count, glucose, lipid and hepatic profiles).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Lidia Daimiel Ruiz, PhD
- Phone Number: 309 +34 917278100
- Email: lidia.daimiel@imdea.org
Study Contact Backup
- Name: Celia Martínez Pérez, PhD
- Phone Number: 310 +34 917278100
- Email: celia.martinez@imdea.org
Study Locations
-
-
-
Madrid, Spain, 28049
- IMDEA Food
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men/women
- 18-50 years old
- BMI 25-40 Kg/m2
- UPF consumption > 35% of total intake in g/day
Exclusion Criteria:
- Pregnancy
- Menopause
- IMC <25 Kg/m2 or > 40 Kg/m2
- Excessive alcohol consumption
- Prevalent cardiovascular, renal, lung, pancreatic or liver disease
- Type 1 diabetes
- Type 2 diabetes with poor glucose control or unstable medication during last 3 months
- Prevalent endocrine disease
- Changes in anti-hypertensive medication during last 3 months
- Insulin, systemic anti-inflammatory, or glucocorticoid medication during last 3 months
- Food allergies or intolerances
- Psychosocial or cultural factors that prevent from following the intervention
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Control Group
Participants in the control group will be provided with nutritional guidelines to follow a healthy diet based on a Mediterranean diet.
|
General counseling to adhere to a healthy Mediterranean diet
|
EXPERIMENTAL: Intervention group
Participants in the intervention group will follow a nutritional intervention program aimed to reduce UPF consumption.
Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention.
Nutritional counseling will be based on nutritional educational material such as encouraged and discouraged food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods.
|
A nutritional intervention program aimed to reduce UPF consumption. Nutritional intervention will not modify basal caloric intake but will record energy intake along the intervention. Nutritional counseling will be based on nutritional educational material such as encouraged and discouraged food items, recipes, menus and food shopping lists based on unprocessed or minimally processed foods. Total intervention will last 6 months for both groups. During the intervention phase, a monthly interview with nutritionist/dietitian is scheduled. Face-to-face interviews will be carried out in months 2 and 4. Phone interviews will be carried out in months 1, 3 and 5. In the baseline and final visits (months 0 and 6) a sample and data collection will be performed.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
UPF
Time Frame: 6 months
|
Ultra-processed food consumption
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight
Time Frame: 6 months
|
Weight change (Kg)
|
6 months
|
BMI
Time Frame: 6 months
|
Change in body mass index (Kg/m2)
|
6 months
|
Obesity
Time Frame: 6 months
|
Percentage of participants who reverse obesity condition (BMI < 30 Kg/m2)
|
6 months
|
Body composition
Time Frame: 6 months
|
Change in % of fat mass
|
6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
DNA methylation
Time Frame: 12 months
|
Reversibility of DNA methylation marks
|
12 months
|
Glucose
Time Frame: 9 months
|
Change in fastin glucose levels (mg/dL)
|
9 months
|
Glycated haemoglobin
Time Frame: 9 months
|
Change in fastin glycated haemoglobin levels (%)
|
9 months
|
Triglycerides
Time Frame: 9 months
|
Change in fasting triglycerides levels (mg/dL)
|
9 months
|
LDL-cholesterol
Time Frame: 9 months
|
Change in fasting LDL-cholesterol levels (mg/dL)
|
9 months
|
HDL-cholesterol
Time Frame: 9 months
|
Change in fasting HDL-cholesterol levels (mg/dL)
|
9 months
|
Liver profile
Time Frame: 9 months
|
Change in HSI liver function index
|
9 months
|
Microbiota
Time Frame: 24 months
|
Changein microbiota diversity
|
24 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Martinez-Perez C, Daimiel L, Climent-Mainar C, Martinez-Gonzalez MA, Salas-Salvado J, Corella D, Schroder H, Martinez JA, Alonso-Gomez AM, Warnberg J, Vioque J, Romaguera D, Lopez-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Sanchez VM, Pinto X, Delgado-Rodriguez M, Matia-Martin P, Vidal J, Vazquez C, Ros E, Basterra J, Babio N, Guillem-Saiz P, Zomeno MD, Abete I, Vaquero-Luna J, Baron-Lopez FJ, Gonzalez-Palacios S, Konieczna J, Garcia-Rios A, Bernal-Lopez MR, Santos-Lozano JM, Bes-Rastrollo M, Khoury N, Saiz C, Perez-Vega KA, Zulet MA, Tojal-Sierra L, Ruiz ZV, Martinez MA, Malcampo M, Ordovas JM, San-Cristobal R. Integrative development of a short screening questionnaire of highly processed food consumption (sQ-HPF). Int J Behav Nutr Phys Act. 2022 Jan 24;19(1):6. doi: 10.1186/s12966-021-01240-6.
- Konieczna J, Morey M, Abete I, Bes-Rastrollo M, Ruiz-Canela M, Vioque J, Gonzalez-Palacios S, Daimiel L, Salas-Salvado J, Fiol M, Martin V, Estruch R, Vidal J, Martinez-Gonzalez MA, Canudas S, Jover AJ, Fernandez-Villa T, Casas R, Olbeyra R, Buil-Cosiales P, Babio N, Schroder H, Martinez JA, Romaguera D; PREDIMED-Plus investigators. Contribution of ultra-processed foods in visceral fat deposition and other adiposity indicators: Prospective analysis nested in the PREDIMED-Plus trial. Clin Nutr. 2021 Jun;40(6):4290-4300. doi: 10.1016/j.clnu.2021.01.019. Epub 2021 Jan 28.
- Martinez-Perez C, San-Cristobal R, Guallar-Castillon P, Martinez-Gonzalez MA, Salas-Salvado J, Corella D, Castaner O, Martinez JA, Alonso-Gomez AM, Warnberg J, Vioque J, Romaguera D, Lopez-Miranda J, Estruch R, Tinahones FJ, Lapetra J, Serra-Majem L, Bueno-Cavanillas A, Tur JA, Sanchez VM, Pinto X, Gaforio JJ, Matia-Martin P, Vidal J, Vazquez C, Ros E, Bes-Rastrollo M, Babio N, Sorli JV, Lassale C, Perez-Sanz B, Vaquero-Luna J, Bazan MJA, Barcelo-Iglesias MC, Konieczna J, Rios AG, Bernal-Lopez MR, Santos-Lozano JM, Toledo E, Becerra-Tomas N, Portoles O, Zomeno MD, Abete I, Moreno-Rodriguez A, Lecea-Juarez O, Nishi SK, Munoz-Martinez J, Ordovas JM, Daimiel L. Use of Different Food Classification Systems to Assess the Association between Ultra-Processed Food Consumption and Cardiometabolic Health in an Elderly Population with Metabolic Syndrome (PREDIMED-Plus Cohort). Nutrients. 2021 Jul 20;13(7):2471. doi: 10.3390/nu13072471.
Helpful Links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IMD: PI-048
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted